Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Completed
National Cancer Institute (NCI)
Phase 3
2003-12-01
RATIONALE: Octreotide may be effective in preventing or controlling diarrhea in patients who
are undergoing chemoradiotherapy for anal or rectal cancer. It is not yet known whether
octreotide is effective in treating diarrhea.
PURPOSE: This randomized phase III trial is studying octreotide in preventing or reducing
diarrhea in patients who are undergoing chemoradiotherapy for anal or rectal cancer.
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Completed
Radiation Therapy Oncology Group
Phase 3
2003-12-01
RATIONALE: Octreotide may be effective in preventing or controlling diarrhea in patients who
are undergoing chemoradiotherapy for anal or rectal cancer. It is not yet known whether
octreotide is effective in treating diarrhea.
PURPOSE: This randomized phase III trial is studying octreotide in preventing or reducing
diarrhea in patients who are undergoing chemoradiotherapy for anal or rectal cancer.
Rifaximin, Loperamide and the Combination to Treat Travelers' Diarrhea
Completed
Bausch Health Americas, Inc.
Phase 4
2004-06-01
Most cases of travelers' diarrhea are caused by bacterial pathogens which respond slowly to
antibiotic treatment.The study was designed to determine the value of rapidly acting
loperamide (imodium) combined with curative dose of the poorly absorbed rifaximin in
travelers' diarreha treatment.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
